Lv11
30 积分 2024-09-14 加入
Impact of TP53 Mutation on Outcome after Allogeneic Stem Cell Transplantation for Patients with MDS/AML Not in Complete Remission
8小时前
待确认
Acute Myeloid Leukemia With Myeloid Sarcoma and Eosinophilia: Prolonged Remission and Molecular Response to Imatinib
18天前
已完结
Successful Treatment of Relapsed and Refractory Extramedullary Acute Promyelocytic Leukemia With Tamibarotene
18天前
已完结
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
18天前
已完结
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia
2个月前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
2个月前
已完结
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53-mutated myeloid malignancies
2个月前
已完结
Mechanism of Initial Favorable Response to Decitabine in TP53 -Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse
2个月前
已完结
Engineering CAR-T therapies for autoimmune disease and beyond.
4个月前
已完结
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
4个月前
已完结
皖公网安备34019202002308
